HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Medicine / Faculty of Medicine >
Peer-reviewed Journal Articles, etc >

Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin

This item is licensed under:Creative Commons Attribution 4.0 International

Files in This Item:
Wang published Journal_of_Experimental_&_Clinical_Cancer_Research.pdf13.11 MBPDFView/Open
Please use this identifier to cite or link to this item:

Title: Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin
Authors: Li, Yi Browse this author
Wu, Anqi Browse this author
Chen, Lin Browse this author
Cai, Aiting Browse this author
Hu, Yuhao Browse this author
Zhou, Zhou Browse this author
Qi, Qianyi Browse this author
Wu, Yixuan Browse this author
Xia, Donglin Browse this author
Dong, Peixin Browse this author →KAKEN DB
Ju, Shaoqing Browse this author
Wang, Feng Browse this author
Keywords: HCC
Drug resistance
Issue Date: 7-Sep-2022
Publisher: BioMed Central
Journal Title: Journal of Experimental & Clinical Cancer Research
Volume: 41
Issue: 1
Start Page: 267
Publisher DOI: 10.1186/s13046-022-02482-3
Abstract: Background:Circular RNA (circRNA) is crucial to the progression of hepatocellular cancer (HCC). In addition, Mito-chondrial calcium uniporter regulatory factor 1 (MCUR1) is commonly overexpressed in HCC to increase cellular ATP levels. Due to the highly aggressive characteristics of HCC, it is essential to identify new diagnostic biomarkers and therapeutic targets that may facilitate the diagnosis of HCC and the development of effective anti-HCC treatments.Methods:A series of in vitro and in vivo experiments were undertaken to investigate the biological importance and underlying mechanisms of circ_0000098 in HCC.Results:The expression of circ_0000098 was higher in HCC tissues compared to paired adjacent tissues. According to the receiver-operating characteristic curves, circ_0000098 functioned as a potential diagnostic tumor marker in HCC. Our experiments indicated that circ_0000098 served as a key oncogenic circRNA to increase HCC cell prolifera-tion and invasion in vitro and HCC progression in vivo. Furthermore, mechanistic investigation demonstrated that by sequestering miR-383 from the 3′-UTR of MCUR1, circ_0000098 positively regulated MCUR1 expression in HCC cells and finally promoted HCC progression. On the other hand, inhibiting circ_0000098 in HCC cells could diminish doxorubicin (DOX) resistance by decreasing P-glycoprotein (P-gp, MDR1) expression and intracellular ATP levels. Either downregulation of MCUR1 or overexpression of miR-383 improved DOX sensitivity in HCC cells. Subsequently, a short hairpin RNA targeting circ_0000098 (referred to as sh-1) and doxorubicin (DOX) were encapsulated into platelets (PLTs), referred to as DOX/sh-1@PLT. Activated DOX/sh-1@PLT through HCC cells resulted in the creation of platelet-derived particles that were capable of delivering the DOX/sh-1 combination into HCC cells and promoting intracellu-lar DOX accumulation. Furthermore, our in vivo experiments showed that DOX/sh-1@PLT can effectively reduce P-gp expression, promote DOX accumulation, and reverse DOX resistance.
Type: article
Appears in Collections:医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 董 培新

Export metadata:

OAI-PMH ( junii2 , jpcoar_1.0 )

MathJax is now OFF:


 - Hokkaido University